To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04250155
Title An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | ESP | CAN | BRA | BEL | AUS

Facility Status City State Zip Country Details
Honor Health Research Institute Scottsdale Arizona 85258 United States Details
Stanford Health Centre - Palo Alto Palo Alto California 94304 United States Details
University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center San Francisco California 94158-2545 United States Details
Yale University New Haven Connecticut 06520 United States Details
City of Hope Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
The University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
Virginia Cancer Specialists (Fairfax) - USOR Fairfax Virginia 22031 United States Details
Parkville Cancer Clinical Trial Unit (PCCTU) Melbourne Victoria 3000 Australia Details
GasthuisZusters Antwerpen Wilrijk 2610 Belgium Details
Hospital de Clinicas de Porto Alegre HCPA PPDS Porto Alegre Rio Grande Do Sul 90560-030 Brazil Details
Instituto do Cancer do Estado de Sao Paulo - ICESP São Paulo 01246-000 Brazil Details
Princess Margaret Hospital Toronto Ontario M5G 2M9 Canada Details
Sir Mortimer B Davis Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
Fondazione IRCCS Istituto Nazionale dei Tumori Milano Lombardia 20133 Italy Details
Istituto Europeo Di Oncologia Milano Lombardia 20141 Italy Details
Istituto Clinico Humanitas Rozzano (MI) Lombardia 20089 Italy Details
Seoul National University Bundang Hospital Seongnam-si 13620 Korea, Republic of Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Severance Hospital Yonsei University Health System - PPDS Seoul 03722 Korea, Republic of Details
Asan Medical Center - PPDS Seoul 05505 Korea, Republic of Details
Samsung Medical Center - PPDS Seoul 06351 Korea, Republic of Details
Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis Amsterdam Noord-Holland 1066 CX Netherlands Details
VU Medisch Centrum Amsterdam 1081 HV Netherlands Details
Universitair Medisch Centrum Groningen Groningen 9713 GZ Netherlands Details
C.H. Regional Reina Sofia - PPDS Córdoba Cordoba 14001 Spain Details
Clinica Universitaria de Navarra Pamplona Navarra 31008 Spain Details
Clinica Universidad de Navarra-Madrid Madrid 28027 Spain Details
START Madrid-FJD, Hospital Fundacion Jimenez Diaz Madrid 28040 Spain Details
Hospital Clinico Universitario de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field